Company Badge
USPTO Data Jan 1 1976 - Oct 6 2026
8 Patents
#541 in San Francisco, CA
#8,531 in California
#35,893 in US
Vir Biotechnology, Inc.
Forward Citations = 8
21 inventors:
San Francisco, CA, United States of America
Vir Biotechnology, Inc.
EPO Patents = 4
Trademarks = 3
Forward Citations = 8
Loading Chart...
Loading Chart...
21 inventors (with patents filed for the assignee):
Florian A Lempp (4 out of 4 patents)
Davide Corti (3 out of 51 patents)
Louis Picker (3 out of 28 patents)
4. Klaus Frueh (3 out of 18 patents)
5. Bette T M Korber (3 out of 9 patents)
6. Eric Bruening (3 out of 4 patents)
7. James Theiler (3 out of 4 patents)
8. Emily Marshall (3 out of 4 patents)
9. Akin Akinc (2 out of 62 patents)
10. James D McIninch (2 out of 34 patents)
11. Mark K Schlegel (2 out of 38 patents)
12. Yesseinia Anglero-Rodriguez (2 out of 3 patents)
13. Christy M Hebner (2 out of 2 patents)
14. Katja Fink (2 out of 2 patents)
15. Martina Beltramello (2 out of 6 patents)
8 patents:
Company Overview
Vir Biotechnology is a clinical-stage immunology company focused on developing novel treatments for infectious diseases. Their innovative research and development programs aim to address global health threats such as COVID-19, Hepatitis B, and HIV. The company's expertise in antibody technology and immunology allows them to create effective therapies to combat these diseases and improve patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vir Biotechnology, Inc.. Retrieved from https://idiyas.com/company/vir-biotechnology
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
4 patents (EPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]